Siegmund Gutman, Life Science Litigation Practice Chair and Patent Litigation Practice Co-Chair, was quoted by Bloomberg Law in an article focused on the biggest patent lawsuits surrounding pharmaceutical drugs and technologies that are set to go to trial in 2026.

Commenting on the Arbutus Biopharma Corp. and Genevant Sciences GmbH’s suit seeking royalties from Moderna Inc.’s Spikevax Covid-19 vaccine, Sige said "the “huge case” will test whether patents with priority dates long predating the pandemic can withstand modern validity scrutiny when applied to a blockbuster vaccine.

Source

Bloomberg Law